Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use Between 2013 and 2017

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0877

Related search